Philip Schoenfeld, MD, MSEd, MSc (Epi) and Elie S. Al Kazzi, MD, MPH discuss “Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY),” Gastroenterology. 2024;167:919–933.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Christopher Velez, MD discuss “Randomised clinical trial: Efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease,” by Fass R, Vaezi M, Sharma P, et al. Aliment Pharmacol Ther. 2023 Nov;58(10):1016-1027.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Margaret Zhou, MD, MS discuss “Colonoscopy quality measures and adherence to follow-up guidelines among endoscopists participating in a U.S. endoscopy registry,” by Shapiro JA, Holub JL, Dominitz JA R, et al. Gastrointest Endosc. 2024 Aug 5:S0016-5107(24)03404-7.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Efficacy and Findings of a Blinded Randomized Reintroduction Phase for the Low FODMAP Diet in Irritable Bowel Syndrome,” by Van den Houte K, Colomier E, Routhiaux K, et al. Gastroenterology. 2024; 167: 333-42.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Douglas K. Rex, MD discuss “Quality Indicators for Colonoscopy,” by Rex DK, Anderson JC, Butterly LF, et al. Am J Gastroenterol. 2024;119:1754-80.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Nicole Rich, MD, MSCS discuss “Impact of longitudinal alcohol use patterns on long-term risk of cirrhosis among US veterans with steatotic liver disease,” by Wong RJ, Yang Z, Cheung R, et al. Gastroenterology. 2024; 166(6):1156-1165.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Philip Okafor, MD, MPH discuss “Stress ulcer prophylaxis during invasive mechanical ventilation,” by Cook D, Deane A, Lauzier F, et al. NEJM. 2024 July 4; 391(1):9-20.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Timothy Yen, MD discuss “Measuring size of colorectal polyps using a virtual scale endoscope or visual assessment: A randomized controlled trial,” by Taghiakbari M, Djinbachian R, Haumesser C, et al. Am J Gastroenterol. 2024 Jul 1;119(7):1309-1317.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Colin Howden, MD discuss “ACG Clinical Guideline: Treatment of Helicobacter pylori Infection,” by Chey W, Howden C, Moss S, et al. Am J Gastroenterol. 2024;119:1730-53.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials,” by Louis E, Schreiber S, Panaccione R, Bossuyt P, et al for the INSPIRE and COMMAND Study Group. JAMA. 2024 Jul 22:e2412414
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Ahmad Abu-Heija, MBBS discuss “Standardised training for endoscopic mucosal resection of large non-pedunculated colorectal polyps to reduce recurrence (*STAR-LNPCP study): a multicentre cluster randomised trial,” by Meulen LWT, Bogie RMM, Siersema PD, et al. Gut. 2024 Apr 5;73(5):741-750
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swathi Eluri, MD, MSCR discuss “Diagnostic Yield of Ambulatory Reflux Monitoring Systems for Evaluation of Chronic Laryngeal Symptoms,” by Krause AJ, Greytak M, Kaizer MA, et al. Am J Gastroenterol. 2024 Apr 1;119(4):627-634.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Bharati Kochar, MD, MS discuss “Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease,” by Peyrin-Biroulet L, Chapman JC, Colombel JF, et al. N Engl J Med 2024;391:213-223.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Christopher Velez, MD discuss “Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial,” by Laine L, Spechler S, and Yadlapati R et al. Clinical Gastroenterology and Hepatology 2024; In Press.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Margaret J. Zhou, MD, MS discuss “Extracorporeal Shock-Wave Lithotripsy and Endoscopy for the Treatment of Pain in Chronic Pancreatitis : A Sham-Controlled, Randomized Trial,” by Talukdar R, Olesen SS, Unnisa M et al. Ann Intern Med 2024 Jun;177(6):749-758.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Elie Al Kazzi, MD, MPH discuss “ACG Clinical Guideline: Gastroparesis,” by Camilleri M, Kuo B, Nguyen L, et al. Am J Gastroenterol 2022;117(8):1197-1220.
Philip Schoenfeld, MD, MSEd, MSc (Epi) discusses “Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis,” by Loomba R, Hartman ML, Lawitz EJ, et al. N Engl J Med June 8, 2024.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Comparison of vonoprazan vs intravenous proton pump inhibitor for prevention of high-risk peptic ulcers rebleeding after successful endoscopic hemostasis: a multicenter randomized noninferiority trial,” by Geeratragool T, Kaosombatwattana U, Boonchote A, et al. Gastroenterology 2024; In Press.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Efficacy and safety of ustekinumab for ulcerative colitis through 4 years: final results of the UNIFI long-term maintenance study,” by Afif W, Arasaradnam RP, Abreu MT, Danese S, et al. Am J Gastroenterol 2024 May 1;119(5):910-921.
Philip Schoenfeld, MD, MSEd, MSc (Epi) and Jacqueline Gaulin discuss “Longer interval between first colonoscopy with negative findings for colorectal cancer and repeat colonoscopy,” by Liang Q, Mukama T, Sundquist K, et al. JAMA Oncology 2024; In Press.